多发性骨髓瘤中T细胞重定向双特异性抗体:目前的情况和未来的方向
Chloe O'Neill1,2, Niels W C J van de Donk1,2
1Amsterdam UMC, Vrije Universiteit Amsterdam Department of Hematology Amsterdam The Netherlands.
EJHaem
|August 21, 2023
概括
参与T细胞双特异性抗体 (BsAbs) 在多发性骨髓瘤 (MM) 患者中显示出显著的疗效. 治疗副作用的管理,如细胞因子释放综合征和感染,对于成功的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 参与T细胞双特异性抗体 (BsAbs) 是多发性骨髓瘤 (MM) 的新型免疫疗法.
- 这些药物在重度预治疗的MM患者中表现出显著的临床活性.
研究的目的:
- 审查BSAbs在多发性骨髓瘤中的疗效和安全性.
- 讨论MM中BsAb疗法的当前挑战和未来方向.
主要方法:
- 对MM中BsAbs的临床试验数据和文献的审查.
- 对反应率,不良事件和管理策略的分析.
主要成果:
- 针对BCMA,GPRC5D或FcRH5的BsAbs在MM中实现60-70%的整体响应率.
- 细胞因子释放综合征和感染是常见的,但可以通过早期干预和预防来控制.
- 针对GPRC5D的BsAbs可以导致皮肤/指甲疾病和味觉丧失.
结论:
- BsAbs在复发性/耐药性MM中有效,目前正在进行试验,探索组合和早期治疗线路.
- 优化BsAb治疗需要仔细管理与免疫相关的毒性和感染.
- 随着T细胞免疫疗法的进展,预计MM患者的治疗结果将进一步改善.
相关概念视频
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
